Public consultation on the interim decision to amend the Poisons Standard in relation to adrenaline - ACMS, June 2025
Overview
Interim decision on proposed amendments to the Poisons Standard in relation to adrenaline.
This consultation is for an interim decision made in relation to adrenaline that was discussed at the JUNE 2025 meetings of the Advisory Committee on Medicines Scheduling (ACMS).
Kindly note that the interim decision published below may differ from the initial proposal. Please read through the proposed interim decisions which can be accessed through the links below and are available on the consultation page for your convenience.
Once you are familiar with the interim decision, please provide your comments and votes in relation to the interim decision.
The closing date for this consultation is close of business 12 JANUARY 2026. All submissions received by the deadline will be considered by the delegate before they make a final decision.
The interim decision under consultation are detailed in the Public notice of the interim decision in relation to adrenaline which can be accessed here.
Audiences
- Aboriginal and Torres Strait Islander People
- Academics
- Aged care professionals
- Aged care service providers
- Aged care workforce
- Biologicals
- BPRU staff
- Businesses
- Carers and guardians
- Commonwealth agencies
- Community groups
- Complementary medicines
- Contracted Service Providers
- Families
- General public
- Graduates
- Health professionals
- Health staff
- Health workforce
- HPRG (TGA) Staff
- Medical Devices & IVDs
- Men
- Non-government organisations
- Online and Publications staff
- Other
- Over-the-counter medicines
- Parents
- PCCD
- Prescription medicines
- Secretariat
- Seniors
- State government agencies
- Women
- Young people
Share
Share on Twitter Share on Facebook